Status:
UNKNOWN
Carbetocin Versus Oxytocin Infusion Plus Tranexamic Acid During Cesarean Section
Lead Sponsor:
Aswan University Hospital
Conditions:
Cesarean Section Complications
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
Purpose to evaluates the effects of oxytocin infusion with or without intravenous tranexamic acid (TA) in comparison with Carbetocin for prevention of postpartum hemorrhage at a cesarean section with ...
Detailed Description
Postpartum hemorrhage (PPH) is potentially life-threatening and is a significant contributor to maternal mortality and morbidity especially in developing countries. The risk of PPH is much higher for ...
Eligibility Criteria
Inclusion
- Women who undergo elective cesarean section with one or more risk factors for PPH were the candidates for participation
- With fetal macrosomia, polyhydramnios, low insertion of the placenta, multiple gestations, prolonged labor, chorioamnionitis, past history of PPH, diabetes and high parity (5 previous deliveries).
Exclusion
- suspected coagulopathy,
- history of coronary artery disease or hypertension,
- women with a history of hypersensitivity to carbetocin, TA or oxytocin
- general anesthesia, and
- PPH due to causes other than uterine atony.
Key Trial Info
Start Date :
January 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2021
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT03777878
Start Date
January 1 2019
End Date
May 1 2021
Last Update
February 15 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aswan University
Aswān, Egypt, 81528